$BLUE Form 8-K

0
594

Form 8-K for BLUEBIRD BIO, INC.


15-Jun-2015

Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.On June 15, 2015, bluebird bio, Inc. (“bluebird”) issued a press release announcing Dr. Philip Gregory’s appointment as bluebird’s Chief Scientific Officer. A copy of this press release is furnished as Exhibit 99.2 to this report on Form 8-K.

On June 15, 2015, bluebird conducted an investor webcast summarizing clinical data from its HGB-205 clinical trial that was presented at an oral presentation at the 20th European Hematology Association Congress in Vienna, Austria on June 13, 2015. A copy of the presentation is being furnished as Exhibit 99.3 to this Report on Form 8-K.

The information in Item 7.01 of this Report on Form 8-K and Exhibits 99.2 and 99.3 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing

Item 8.01 Other Events.On June 13, 2015, bluebird issued a press release announcing clinical data from its HGB-205 clinical trial at an oral presentation at the 20th European Hematology Association Congress in Vienna, Austria on June 13, 2015. The full text of bluebird’s press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.(d) Exhibits

Exhibit No. Description
99.1        Press release issued by bluebird bio, Inc.
            on June 13, 2015.
99.2        Press release issued by bluebird bio, Inc.
            on June 15, 2015.
99.3        Investor presentation provided by bluebird
            bio, Inc. on June 15, 2015.

LEAVE A REPLY

Please enter your comment!
Please enter your name here